City of Hope scientists are using combination immunotherapy to treat advanced cancers
(City of Hope) City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly-impossible-to-treat cancer into a disease that can be corralled into remission. Daneng Li, M.D., is treating patients with advanced liver (hepatocellular) cancer, while Joseph Chao, M.D., is treating patients with advanced stomach and esophageal cancer (gastric and gastroesophageal junction adenocarcinoma). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 8, 2019 Category: Cancer & Oncology Source Type: news

Neoadjuvant Chemotherapy Key to Survival in Pancreatic Cancer
Three factors independently linked to prolonged survival in BR/LA pancreatic ductal adenocarcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 4, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Surgery, Journal, Source Type: news

Neoadjuvant Chemotherapy Key to Survival in Pancreatic Cancer
THURSDAY, April 4, 2019 -- Three factors can predict survival in patients with borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC), according to a study published online April 2 in the Annals of Surgery. Mark... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 4, 2019 Category: Pharmaceuticals Source Type: news

Favorable Results Seen With APX005M in Combination Therapy for Metastatic Ductal Pancreatic Adenocarcinoma
Cancer Network spoke with Mark H. O'Hara, MD, about the safety and efficacy of APX005M in combination with standard chemotherapy with or without nivolumab. (Source: CancerNetwork)
Source: CancerNetwork - April 4, 2019 Category: Cancer & Oncology Authors: Mark H. O & #039;Hara, MD Source Type: news

Tumor microenvironment analyzed to increase effectiveness of preclinical trials
(Kazan Federal University) It was shown that co-culturing HeLa adenocarcinoma cells, peripheral blood mononuclear cells, and mesenchymal stromal cells results in changes in the proliferative activity of the peripheral blood mononuclear cells and mesenchymal stromal cell populations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 2, 2019 Category: Cancer & Oncology Source Type: news

Radiomic Features May Predict Response to Chemo in NSCLC
TUESDAY, March 26, 2019 -- For patients with lung adenocarcinoma, radiomic texture features extracted from within and around the nodule on baseline computed tomography (CT) scans can predict response to chemotherapy, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2019 Category: Pharmaceuticals Source Type: news

Car accident with airbag deployment trauma showed special pattern in bone scan - Chuang TL, Hsu TW, Chou SC, Wang YF.
A 72-year-old man had rectal adenocarcinoma with partial obstruction with liver and lung metastases. Bone scan showed special pattern with bony destructions to the lateral aspect of the left first to fourth and right first to 10th ribs (in a row in continu... (Source: SafetyLit)
Source: SafetyLit - March 24, 2019 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Adenocarcinoma, High - Grade Dysplasia Up With Barrett Esophagus
But Barrett esophagus length has decreased, as has prevalence of low - grade dysplasia on endoscopy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 18, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pathology, Journal, Source Type: news

Adenocarcinoma, High-Grade Dysplasia Up With Barrett Esophagus
MONDAY, March 18, 2019 -- The prevalence of high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) has significantly increased since 1995 in patients with Barrett esophagus (BE), according to a study published in the February issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2019 Category: Pharmaceuticals Source Type: news

Two for the price of one: Mechanistic insights lead to drug repositioning
(University of Tsukuba) A University of Tsukuba-led team confirmed that the binding of the cancer-promoting protein stratifin to phosphorylated SKP1 prevents the formation of a ubiquitinating enzyme complex. This hinders the degradation of several oncoproteins, which promotes lung adenocarcinogenesis. The team then used in silico, in vitro, and in vivo analyses to identify and test drugs that inhibit this binding, with two drugs successfully reducing tumor development and progression. This work raises hopes in the fight against lung adenocarcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 7, 2019 Category: Cancer & Oncology Source Type: news

A New Machine Learning Model can Classify Lung Cancer Slides at the Pathologist Level
Machine learning has improved dramatically in recent years and shown great promise in the field of medical image analysis. A team of research specialists at Dartmouth's Norris Cotton Cancer Center have utilized machine learning capabilities to assist with the challenging task of grading tumor patterns and subtypes of lung adenocarcinoma, the most common form of the leading cause of cancer-related deaths worldwide. (Source: eHealth News EU)
Source: eHealth News EU - March 4, 2019 Category: Information Technology Tags: Featured Research Research and Development Source Type: news

Decline Observed in HPV Type 16/18 Cervical Precancers in U.S.
WEDNESDAY, Feb. 27, 2019 -- The proportion of human papillomavirus (HPV) 16/18-positive cervical intraepithelial neoplasia grades 2 to 3 or adenocarcinoma in situ (CIN2+) declined from 2008 to 2014, according to a study published online Feb. 21 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 27, 2019 Category: Pharmaceuticals Source Type: news

Newly identified drug targets could open door for esophageal cancer therapeutics
(Case Western Reserve University) Blocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in the United States, according to new research out of Case Western Reserve University School of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 27, 2019 Category: Cancer & Oncology Source Type: news

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
(Rapamycin Press) Among many pathways of cancer progression that PDAC relies on, anomalous activation of the sonic hedgehog pathway has shown in a variety of human cancers, including, basal cell carcinoma, malignant gliomas, medulloblastoma, leukemias, and cancers of the breast, lung, pancreas, and prostate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2019 Category: Cancer & Oncology Source Type: news

FDA Approves Taiho Oncology's LONSURF(R) (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
PRINCETON, N.J., Feb. 25, 2019 -- (Healthcare Sales & Marketing Network) -- Taiho Oncology, Inc. today announced that the United States Food and Drug Administration (FDA) has approved LONSURF® as a treatment for adult patients with metastatic gastric ... Biopharmaceuticals, Oncology, FDA Taiho Oncology, LONSURF, trifluridine, tipiracil, Gastric cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 25, 2019 Category: Pharmaceuticals Source Type: news

Mother was forced to have her EYE removed after a rare cancer spread across her face  
Toni Crews, 29, of Deal, Kent, began battling blurred vision and headaches in July 2016. She was diagnosed with adenocarcinoma - a type of cancer in the gland of her right eye. (Source: the Mail online | Health)
Source: the Mail online | Health - February 25, 2019 Category: Consumer Health News Source Type: news

FDA Approves Lonsurf (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
PRINCETON, N.J., February 25, 2019– Taiho Oncology, Inc. today announced that the United States Food and Drug Administration (FDA) has approved Lonsurf as a treatment for adult patients with metastatic gastric or gastroesophageal junction... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 25, 2019 Category: Drugs & Pharmacology Source Type: news

Results of early endoscopic exam critical for assessment of Barrett's patients
(American Society for Gastrointestinal Endoscopy) A new study indicates that both high-grade abnormal cellular changes (dysplasia) and esophageal adenocarcinoma (a form of cancer) have increased in the last 25 years among people with a digestive condition known as Barrett's esophagus. The study report, Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades, is published in the February issue of GIE: Gastrointestinal Endoscopy, the peer-reviewed journal of the American Society for Gastrointestinal Endoscopy (ASGE). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2019 Category: International Medicine & Public Health Source Type: news

Mapping oesophageal cancer genes leads to new drug targets
(Cancer Research UK) Mutations that cause oesophageal adenocarcinoma (OAC) have been mapped in unprecedented detail -- unveiling that more than half could be targeted by drugs currently in trials for other cancer types. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 4, 2019 Category: Biology Source Type: news

Reading the signs: Semaphorin linked to lung cancer treatment resistance
(Osaka University) Osaka University researchers showed that high levels of the protein Semaphorin 7a are associated with resistance to treatment with EGFR-TKIs in lung adenocarcinoma cells with EGFR mutation. The findings revealed the involvement of mTOR signaling in this effect, as well as the importance of the inhibition of apoptosis. The findings suggest that focusing on Semaphorin 7a could be advantageous for predicting the prognosis of lung cancer patients and potentially for treating them. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 10, 2019 Category: Cancer & Oncology Source Type: news

Adjuvant Therapy Questioned for Patients With Small Pancreatic Tumors
Investigators evaluated whether patients with pancreatic ductal adenocarcinoma benefit from adjuvant therapy after surgery if the tumor is smaller than 1 cm. (Source: CancerNetwork)
Source: CancerNetwork - January 4, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

Pembrolizumab Shows Modest Activity in Advanced Esophageal Cancer Pembrolizumab Shows Modest Activity in Advanced Esophageal Cancer
Pembrolizumab benefits a minority of heavily pretreated patients with advanced metastatic adenocarcinoma or squamous cell carcinoma of the esophagus, according to an open-label phase 2 trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 28, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Bladder Cancer | Medscape Bladder Cancer | Medscape
Bladder cancer is the second most common urologic malignancy. Transitional cell carcinoma accounts for more than 90% of cases; other types include squamous cell carcinoma and adenocarcinoma. In stage 1 disease, when the tumors are superficial, bladder cancer is treatable with transurethral resection and intravesical therapy. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news

VARGADO data
Vargatef ® plus docetaxel could be an option after failure of immunotherapy in lung cancerResults from a real-world study1  support a recent update to the ESMO guidelines2 recommending nintedanib (Vargatef®) plus docetaxel following first-line chemotherapy (+/- immunotherapy) in advanced NSCLC of adenocarcinoma histology (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - December 13, 2018 Category: Research Source Type: news

Intraoperative Consultation on Surgical Margins 98% Accurate in Gastric Cancer Intraoperative Consultation on Surgical Margins 98% Accurate in Gastric Cancer
The false-negative rate of intraoperative consultation (IOC) on surgical margins during resection of gastric and gastroesophageal adenocarcinoma is less than 2% overall, according to a retrospective study at a specialty center.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 6, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Short-term ADT with RT improves survival over RT alone up to 10 years
(NRG Oncology) The long-term follow up of the NRG Oncology trial RTOG 9408, studying the addition of short-term androgen-deprivation therapy (ADT) to radiotherapy (RT) for men with early, localized prostate adenocarcinoma, indicated that RT combined with ADT is superior to RT alone for overall survival (OS) up to 10.4 years following treatment. However, when researchers assessed these results up to 18 years, the benefits of adding ADT to RT dissipated. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 22, 2018 Category: International Medicine & Public Health Source Type: news

Pancreatic cancer genetic marker may predict outcomes with radiation therapy
(Thomas Jefferson University) scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer. The discovery may help physicians provide better treatment options for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

Increased survival in patients with metastatic NSCLC receiving treatment in academic centers
(International Association for the Study of Lung Cancer) Patients with metastatic NSCLC receiving treatment at academic centers (ACs) have an increased 2-year survival compared to patients treated at community-based centers (CCs). An overall histology-dependent survival was also noted in patients with adenocarcinoma verses squamous cell carcinoma and varied by treatment facility. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 10, 2018 Category: Cancer & Oncology Source Type: news

UCLA researchers discover aggressive prostate and lung cancers are driven by common mechanisms
UCLA researchers have discovered a common process in the development of late-stage, small cell cancers of the prostate and lung. These shared molecular mechanisms could lead to the development of drugs to treat not just prostate and lung cancers, but small cell cancers of almost any organ.The key finding: Prostate and lung cells have very different patterns of gene expression when they ’re healthy, but almost identical patterns when they transform into small cell cancers. The research suggests that different types of small cell tumors evolve similarly, even when they come from different organs.The study, led by Dr. O...
Source: UCLA Newsroom: Health Sciences - October 5, 2018 Category: Universities & Medical Training Source Type: news

Nano-Optic Endoscope Offers Anatomic Pathologists, Medical Laboratories Higher Resolution and Precision Optical Imaging
New metalens technology from MGH and SEAS researchers gives greater endoscopic optical imaging resolution and sample detail for anatomic pathologists performing diagnostics Anatomic pathologists and clinical laboratories know that biopsy samples are necessary to diagnose many diseases. But, current endoscopic imaging techniques used by physicians sometimes fail to clearly visualize disease sites. Consequently, biopsies collected […] (Source: Dark Daily)
Source: Dark Daily - September 26, 2018 Category: Laboratory Medicine Authors: Jude Tags: Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Laboratory Testing Management & Operations adenocarcinoma anatomic path Source Type: news

Is AI the Key to Diving Deeper into Images and Pathology?
In a tale of two studies, it appears artificial intelligence is helping researchers analyze cells in ways that weren't possible before. In one study, published this week in Nature Methods, scientists at the Allen Institute in Seattle, WA used machine learning to train computers to see parts of the cell that the human eye cannot easily distinguish. Using 3D images of fluorescently labeled cells, the team taught computers to find structures inside living cells without fluorescent labels, using only black and white images generated by an inexpensive technique known as brightfield microscopy. Fluorescence microscop...
Source: MDDI - September 19, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news

Reducing Risk of Esophageal Cancer in Barrett's Esophagus Reducing Risk of Esophageal Cancer in Barrett's Esophagus
Patients with Barrett's esophagus have a high risk of developing esophageal adenocarcinoma. Can PPIs and H2 receptor antagonists mitigate the risk?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 18, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Circulating Tumor Cell Dynamics in Pancreatic Adenocarcinoma Circulating Tumor Cell Dynamics in Pancreatic Adenocarcinoma
What is the clinical significance of circulating tumor cells in pancreatic ductal adenocarcinoma?Annals of Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 10, 2018 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

Barrett's Tied to Better Survival in Esophageal Ca
(MedPage Today) -- Data suggests existence of two distinct types of esophageal adenocarcinoma (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - September 6, 2018 Category: Gastroenterology Source Type: news

Endocervical Cells With Gastric-Type Mucin on Pap Smears Endocervical Cells With Gastric-Type Mucin on Pap Smears
Does gastric-type mucin observed on Pap smears provide diagnostic value for endocervical adenocarcinoma and its precursors?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 4, 2018 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Could HPV Be Prognostic in Esophageal Cancer Too? Could HPV Be Prognostic in Esophageal Cancer Too?
HPV positivity is associated with significantly better outcomes in patients with Barrett's high-grade dysplasia or esophageal adenocarcinoma, suggesting less intensive therapy might be considered.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 3, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Post-Prostatectomy Radiation Therapy: Patient Selection, Timing, Imaging, and Therapy Intensification
A 62-year-old man with prostate adenocarcinoma elected to proceed with radical prostatectomy as definitive management. After his pathology report showed stage IIIB disease, he elected for observation. What happened next? (Source: CancerNetwork)
Source: CancerNetwork - July 18, 2018 Category: Cancer & Oncology Authors: Tyler P. Robin, MD, PhD, Paul D. Maroni, MD, Bennett B. Chin, MD, Francisco G. La Rosa, MD, Brandon Bernard, MD, MPH, Thomas J. Pugh, MD Source Type: news

Complex Glandular Patterns in Lung Adenocarcinoma Complex Glandular Patterns in Lung Adenocarcinoma
This study provides new insight into the potential role of complex glandular patterns in clinical management of lung adenocarcinoma.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 10, 2018 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Survival in Pancreatic Cancer With Germline Mutations Survival in Pancreatic Cancer With Germline Mutations
Platinum-based therapy may improve survival in pancreatic ductal adenocarcinoma carrying deleterious germline mutations.JCO Precision Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Five-year survival rate for most common pancreatic cancer just 3%
The “outrageous” five‐year survival rate in England for patients with the most common type of pancreatic cancer ‐ pancreatic ductal adenocarcinoma (PDAC) ‐ has been revealed for the first time in a study, commissioned by the charity Pancreatic Cancer UK (Source: Nursing Times)
Source: Nursing Times - June 20, 2018 Category: Nursing Source Type: news

Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases
The majority of patients with pancreatic ductal adenocarcinoma (PDA) develop metastatic disease after resection of their primary tumor. We found that livers from patients and mice with PDA harbor single disseminated cancer cells (DCCs) lacking expression of cytokeratin 19 (CK19) and major histocompatibility complex class I (MHCI). We created a mouse model to determine how these DCCs develop. Intraportal injection of immunogenic PDA cells into preimmunized mice seeded livers only with single, nonreplicating DCCs that were CK19– and MHCI–. The DCCs exhibited an endoplasmic reticulum (ER) stress response but parad...
Source: ScienceNOW - June 14, 2018 Category: Science Authors: Pommier, A., Anaparthy, N., Memos, N., Kelley, Z. L., Gouronnec, A., Yan, R., Auffray, C., Albrengues, J., Egeblad, M., Iacobuzio-Donahue, C. A., Lyons, S. K., Fearon, D. T. Tags: Medicine, Diseases, Online Only r-articles Source Type: news

ASCO: mFOLFIRINOX Improves Survival in Pancreatic Cancer
MONDAY, June 4, 2018 -- The oxaliplatin, leucovorin, irinotecan, and 5-fluorouracil (mFOLFIRINOX) regimen is associated with longer median disease-free and overall survival in pancreatic ductal adenocarcinoma; and, receiving chemotherapy before... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2018 Category: Pharmaceuticals Source Type: news

Worse Survival for BRCA Germline Mutation Carriers in Pancreatic CA
WEDNESDAY, May 30, 2018 -- BRCA1/BRCA2 germline mutation carriers with pancreatic ductal adenocarcinoma (PDAC) have worse survival after resection, according to a study published in the April issue of the Journal of the American College of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 30, 2018 Category: Pharmaceuticals Source Type: news

Mortality Risk Persists for Cancer Tied to Prenatal DES Exposure
Women with DES - related clear - cell adenocarcinoma had 27 - fold higher mortality at 10 to 34 years (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 3, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Journal, Source Type: news

Mortality Risk Persists for Cancer Tied to Prenatal DES Exposure
THURSDAY, May 3, 2018 -- Diethylstilbestrol (DES)-related clear-cell adenocarcinoma of the vagina and cervix is associated with increased risk of death, even in older women, according to a letter to the editor published in the May 3 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2018 Category: Pharmaceuticals Source Type: news

The DES saga: Death risk high for young women exposed in utero
(University of Chicago Medical Center) A letter in the May 3, 2018, NEJM updates reports on the risks of exposure during pregnancy to a supplement, diethylstilbestrol (DES), that is linked to a rare cancer. The study found that DES-exposed patients with clear-cell adenocarcinoma had 'increased mortality across their life span.' For women aged 10 to 34 with DES-related clear-cell adenocarcinoma, the risk of death was 27 times higher than for other US women in that age group. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 2, 2018 Category: Cancer & Oncology Source Type: news

Novel theranostic approach for treating pancreatic cancer patients shows promise
(Society of Nuclear Medicine and Molecular Imaging) German researchers have developed a novel diagnostic and therapeutic (theranostic) procedure for patients with ductal pancreatic adenocarcinoma, a deadly cancer with an extremely poor prognosis (five-year survival rate of less than 5 percent) and limited treatment options. The study is featured in the May issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

Metastatic Adenocarcinoma Involving Atypical Meningioma Metastatic Adenocarcinoma Involving Atypical Meningioma
A patient with a history of stage IV lung adenocarcinoma presented to the emergency department with aphasia. What was the cause?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 30, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Presence and amount of gut bacteria can predict how fast pancreatic cancer cells grow
(Natural News) Pancreatic ductal adenocarcinoma, or PDA, is the most common and by far the most lethal form of pancreatic cancer. Pancreapedia reports that it is extremely aggressive, and for most patients their only hope of survival hinges on the total surgical removal of the tumor. Unfortunately, such tumors cannot be removed in upwards of... (Source: NaturalNews.com)
Source: NaturalNews.com - April 25, 2018 Category: Consumer Health News Source Type: news

CDx & #039;s WATS3D Highly Effective in Real World Setting
CDx Diagnostics said results from a recent multicenter prospective trial show the use of its WATS3D test increases the detection of both Barrett’s esophagus and esophageal dysplasia by more than 80%. The results were published in the latest issue of United European Gastroenterology Journal and featured in the American Society for Gastrointestinal Endoscopy (ASGE’s) Scope Tech Talk Video Series. The trial was conducted at 25 community-based gastrointestinal (GI) centers across the U.S. In the study, 4,203 patients were tested for esophageal disease. The findings show that with the inclusion of WATS3D overal...
Source: MDDI - March 26, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Design News Source Type: news